⚡️ Dario Amodei: AI could help double the human lifespan

Anthropic CEO Dario Amodei has argued that AI could dramatically accelerate biology, potentially compressing a century of scientific progress into just 5–10 years.

The longevity race is already attracting major tech fortunes. Jeff Bezos has backed Altos Labs, Sam Altman is involved with Retro Biosciences, and Peter Thiel is associated with NewLimit. Their shared ambition is to understand aging and develop ways to extend healthy human life.

Some of this research is moving beyond the laboratory. Retro Biosciences, for example, is pursuing therapies aimed at improving cellular health, while scientists are exploring ways to reverse aspects of cellular aging. But these approaches remain experimental, and doubling human lifespan is far from a proven outcome.

The bigger possibility is that AI could accelerate drug discovery, uncover mechanisms of aging and help researchers develop treatments that would otherwise take decades to discover.

That makes the next decade particularly interesting for longevity science. We don’t know when major breakthroughs will arrive, or whether they will deliver the results people hope for.

Until then, protecting your health today may be the most practical way to give yourself the opportunity to benefit from tomorrow’s medicine.

@aipost 🏴